SEC Company Response from GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416) (GALT) — Apr 10, 2019
GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416)
Date: April 10, 2019 · CIK: 0001133416 · Accession: 0001193125-19-102831
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230085
Letter
Re: Galectin Therapeutics, Inc.
April 10, 2019
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-0405
Registration Statement on Form S-3/A
File No. 333-230085
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on April 10, 2019, in which we, Galectin Therapeutics, Inc., (the “Company”) requested, pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, that the above-referenced registration statement be accelerated to 3:00 p.m., Eastern Time, on Wednesday, April 10, 2019, or as soon thereafter as practicable.
We are no longer requesting that such Registration Statement be declared effective at such time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
/s/ Jack W. Callicutt
Show Raw Text
CORRESP 1 filename1.htm CORRESP April 10, 2019 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-0405 Re: Galectin Therapeutics, Inc. Registration Statement on Form S-3/A File No. 333-230085 Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on April 10, 2019, in which we, Galectin Therapeutics, Inc., (the “Company”) requested, pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, that the above-referenced registration statement be accelerated to 3:00 p.m., Eastern Time, on Wednesday, April 10, 2019, or as soon thereafter as practicable. We are no longer requesting that such Registration Statement be declared effective at such time and we hereby formally withdraw our request for acceleration of the effective date. Very truly yours, /s/ Jack W. Callicutt Jack W. Callicutt Chief Financial Officer